Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amer Omar

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Pharmacogenetics and Genomics|October 2, 2015
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degenerationLaura Lorés-Motta, Freekje van Asten, Philipp S Muether, et al.
Molecular Genetics & Genomic Medicine|January 29, 2015
Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti's retinal dystrophyGaluh D N Astuti, Vincent Sun, Miriam Bauwens, et al.
Ophthalmology|July 31, 2012
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degenerationDzenita Smailhodzic, Philipp S Muether, John Chen, et al.
Journal of the Endocrine Society|February 2, 2026
Molecular Genetics of 1α-Hydroxylase Deficiency in the Saudi PopulationBassam Bin-Abbas, Afaf Alsagheir, Balgees Alghamdi, et al.
Scientific Reports|November 29, 2016
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degenerationMoeen Riaz, Laura Lorés-Motta, Andrea J Richardson, et al.
Investigative Ophthalmology & Visual Science|June 18, 2010
Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizationsKarin W Littink, Robert K Koenekoop, L Ingeborgh van den Born, et al.
JAMA Ophthalmology|June 1, 2018
Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular DegenerationLaura Lorés-Motta, Moeen Riaz, Michelle Grunin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Pharmacogenetics and Genomics|October 2, 2015
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degenerationLaura Lorés-Motta, Freekje van Asten, Philipp S Muether, et al.
Molecular Genetics & Genomic Medicine|January 29, 2015
Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti's retinal dystrophyGaluh D N Astuti, Vincent Sun, Miriam Bauwens, et al.
Ophthalmology|July 31, 2012
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degenerationDzenita Smailhodzic, Philipp S Muether, John Chen, et al.
Journal of the Endocrine Society|February 2, 2026
Molecular Genetics of 1α-Hydroxylase Deficiency in the Saudi PopulationBassam Bin-Abbas, Afaf Alsagheir, Balgees Alghamdi, et al.
Scientific Reports|November 29, 2016
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degenerationMoeen Riaz, Laura Lorés-Motta, Andrea J Richardson, et al.
Investigative Ophthalmology & Visual Science|June 18, 2010
Homozygosity mapping in patients with cone-rod dystrophy: novel mutations and clinical characterizationsKarin W Littink, Robert K Koenekoop, L Ingeborgh van den Born, et al.
JAMA Ophthalmology|June 1, 2018
Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular DegenerationLaura Lorés-Motta, Moeen Riaz, Michelle Grunin, et al.
Pageof 2